Insights Home Insights Featured Content Q&As Inside the FDA: Insights from Former Regulators What forces are shaping today’s regulatory environment? In this latest Q&A, we asked our Former FDA Expert Team to weigh in on some of the most pressing questions facing the Agency and the industries it oversees. Q&As A Robotics Expert’s Outlook on AI and Automation To unpack the evolving landscape of robotics and AI-driven vehicles, we spoke with Dr. Moiz Khan, an accomplished engineer and AI expert whose work spans autonomous system design, machine learning, and regulatory compliance for safety-critical technologies. Press Release DOAR Unifies Expert Witness and Litigation Strategy Businesses The integration will bring together leading litigation strategy consultants and the most qualified testifying expert witnesses under one roof. Article Key Takeaways from ALJ Johnson Hines’ Fireside Chat for ITCTLA WIT Director, Jeffrey Dorfman, recently attended ITCTLA's panel and procedure event and took note of ALJ Johnson Hines’s practical guidance. Article Cryptocurrency Litigation: Parent Companies and Industry Segments at a Glance To stay ahead of litigation trends in fast-changing markets, WIT analyzes disputes in our core practice areas to spot patterns and anticipate where the next wave of challenges may emerge. Our latest deep dive focuses on crypto parent-company activity in federal district courts. Insights & News All Focus Areas Automotive Cryptocurrency Financial Technology Former FDA Gaming Hatch-Waxman Litigation Healthcare Technology & Medical Devices ITC Investigations Pharmaceutical Wireless Communications All Insight Types Archive Article Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Q&As Report Video Search April 11, 2025 — Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial.
Q&As Inside the FDA: Insights from Former Regulators What forces are shaping today’s regulatory environment? In this latest Q&A, we asked our Former FDA Expert Team to weigh in on some of the most pressing questions facing the Agency and the industries it oversees.
Q&As A Robotics Expert’s Outlook on AI and Automation To unpack the evolving landscape of robotics and AI-driven vehicles, we spoke with Dr. Moiz Khan, an accomplished engineer and AI expert whose work spans autonomous system design, machine learning, and regulatory compliance for safety-critical technologies.
Press Release DOAR Unifies Expert Witness and Litigation Strategy Businesses The integration will bring together leading litigation strategy consultants and the most qualified testifying expert witnesses under one roof.
Article Key Takeaways from ALJ Johnson Hines’ Fireside Chat for ITCTLA WIT Director, Jeffrey Dorfman, recently attended ITCTLA's panel and procedure event and took note of ALJ Johnson Hines’s practical guidance.
Article Cryptocurrency Litigation: Parent Companies and Industry Segments at a Glance To stay ahead of litigation trends in fast-changing markets, WIT analyzes disputes in our core practice areas to spot patterns and anticipate where the next wave of challenges may emerge. Our latest deep dive focuses on crypto parent-company activity in federal district courts.
April 11, 2025 — Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial.
